Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study In Patients With Overactive Bladder (OAB) Treated With Toviaz® After Failure Of Previous Antimuscarinic Therapy Due To Ineffectivity Or Intolerance.

NCT00691093 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00691093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00691093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study In Patients With Overactive Bladder (OAB) Treated With Toviaz® After Failure Of Previous Antimuscarinic Therapy Due To Ineffectivity Or Intolerance.
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
July 31, 2008
Completion date
June 30, 2009
Enrollment
823 (actual)
Sites
65

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder, urinary incontinence